Prominent regression of corneal deposits in Fabry disease 16years after initiation of enzyme replacement therapy

被引：6

作者：

Koh, Shizuka ^{[1
,2
]}

Sakai, Norio ^{[3
]}

Maeda, Naoyuki ^{[2
]}

Nishida, Kohji ^{[2
]}

机构：

[1] Osaka Univ, Dept Innovat Visual Sci, Grad Sch Med, Room E7,2-2 Yamadaoka, Suita, Osaka 5650871, Japan

[2] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Osaka, Japan

[3] Osaka Univ, Dept Paediat, Grad Sch Med, Osaka, Japan

来源：

ACTA OPHTHALMOLOGICA | 2018年 / 96卷 / 02期

关键词：

10-YEAR;

D O I：

10.1111/aos.13541

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：e255 / e256

页数：2

共 5 条

[1] Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement [J].

Fledelius, Hans C. ;

Sandfeld, Lisbeth ;

Rasmussen, Ase Krogh ;

Madsen, Christoffer V. ;

Feldt-Rasmussen, Ulla .

ACTA OPHTHALMOLOGICA, 2015, 93 (03) :258-264

[2] Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease [J].

Germain, Dominique P. ;

Charrow, Joel ;

Desnick, Robert J. ;

Guffon, Nathalie ;

Kempf, Judy ;

Lachmann, Robin H. ;

Lemay, Roberta ;

Linthorst, Gabor E. ;

Packman, Seymour ;

Scott, C. Ronald ;

Waldek, Stephen ;

Warnock, David G. ;

Weinreb, Neal J. ;

Wilcox, William R. .

JOURNAL OF MEDICAL GENETICS, 2015, 52 (05) :353-358

[3] A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry disease [J].

Schiffmann, Raphael ;

Swift, Caren ;

Wang, Xuan ;

Blankenship, Derek ;

Ries, Markus .

JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (06) :1129-1136

[4]

SHER NA, 1979, ARCH OPHTHALMOL-CHIC, V97, P671

[5]

Sodi A., 2006, Fabry Disease: Perspectives from 5 Years of FOS

← 1 →